Legal Blog

Pennsylvania, Here We Come: Medical Marijuana Legislation Signed into Law

medicalmarijaunaThe medical marijuana community scored another big win early this week when Pennsylvania Governor Tom Wolf signed into law the Commonwealth’s new medical marijuana law. As the 24th state to enact such legislation, the tide is unmistakably turning toward a majority of this nation having legal marijuana in one form or another. Pennsylvania’s law is in many ways unique. For example, the law prohibits patients from purchasing or obtaining dry product or from smoking the substance (although this could change in the future). Instead, the law permits patients to obtain pills, oils, topical gels or creams, tinctures, and liquids, as well as to receive treatment through vaporization or nebulization. Smoking marijuana remains illegal, although edibles are explicitly permitted. The law will have oversight from a newly-created Medical Marijuana Advisory Board, under the aegis of the Commonwealth’s Department of Health. The Advisory Board will begin putting together regulations shortly. Although we are still hard at work reviewing and analyzing the newly-enacted law, here are some salient components:

  • The Department will issue 25 combined grower/processor licenses, as well as 50 dispensary permits. Each dispensary is permitted up to 3 locations, which means a potential total of 150 dispensaries across the Commonwealth.
  • Medical insurers—both public and private—are not required to reimburse for any costs related to the use of medical marijuana
  • Qualifying medical conditions include cancer, amyotrophic lateral sclerosis, Parkinson’s disease, multiple sclerosis, epilepsy, inflammatory bowel disease, Huntington’s disease, Crohn’s disease, post-traumatic stress disorder, intractable seizures, glaucoma, sickle cell anemia, and chronic pain, among others. Additionally, Pennsylvania’s law includes autism as one of the qualifying medical conditions.
  • Physicians and other prescribers must register and undergo training to prescribe marijuana, and patients must be under the ongoing care of a registered physician to obtain marijuana
  • Employers can prohibit the use of medical marijuana by employees on the job, but are unable to discharge, threaten, refuse to hire, or otherwise discriminate or retaliate against an employee on the basis of their certification to use medical marijuana
  • Application fees for the program range from $5,000.00 to $10,000 per facility, and registration fees range from $30,000 to $200,000 per location
  • Dispensaries must staff a physician, pharmacist, physician assistant, or certified registered nurse practitioner on site at all times

If you would like to learn more about Pennsylvania’s medical marijuana program, are interested in applying for a license, or are in an industry affected by the legislation, please join me at our free seminar on Medical Marijuana in the Commonwealth of Pennsylvania in Philadelphia on May 24, 2016 (additional details forthcoming). Please also feel free to contact me directly.


Offit Kurman is one of the fastest-growing, full-service law firms in the Mid-Atlantic region. With over 140 attorneys offering a comprehensive range of services in virtually every legal category, the firm is well positioned to meet the needs of dynamic businesses and the people who own and operate them. Our eleven offices serve individual and corporate clients in the Virginia, Washington, DC, Maryland, Delaware, Pennsylvania, New Jersey, and New York City regions. At Offit Kurman, we are our clients’ most trusted legal advisors, professionals who help maximize and protect business value and personal wealth. In every interaction, we consistently maintain our clients’ confidence by remaining focused on furthering their objectives and achieving their goals in an efficient manner. Trust, knowledge, confidence—in a partner, that’s perfect.

You can connect with Offit Kurman via our Blog, Facebook, Twitter, Google+, YouTube, and LinkedIn pages. You can also sign up to receive Law Matters, Offit Kurman’s monthly newsletter covering a diverse selection of legal and corporate thought leadership content.